SHORT MINI-FUTURE - AMGEN | Delayed Deutsche Boerse AG 01:46:44 2024-06-14 pm EDT | ||
| 5.53 EUR | +1.47% |
|
| Current month | +14.73% | ||
| 1 month | +21.01% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-14 | 5.53 | +1.47% |
| 24-06-13 | 5.45 | +5.62% |
| 24-06-12 | 5.16 | -1.34% |
| 24-06-11 | 5.23 | +5.02% |
| 24-06-10 | 4.98 | +6.64% |
Delayed Quote Deutsche Boerse AG
Last update June 14, 2024 at 01:46 pm EDT
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VU1MCA |
| ISIN | DE000VU1MCA7 |
| Date issued | 2023-01-04 |
| Strike | 356.9 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 9.78 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.57 € |
|---|---|
| Lowest since issue | 3.04 € |
| Spread | 0.14 € |
| Spread % | 2.53% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
298.6
USD
Average target price
316.4
USD
Spread / Average Target
+5.97%
- Stock Market
- Certificates
- Certificat
